Mode
Text Size
Log in / Sign up
N/A Completed N=92 Randomized Single-blind Treatment

Effectiveness and Safety of Restylane Lyft With Lidocaine in the Dorsal Hand

Volume Deficit in the Hand
Source: ClinicalTrials.gov NCT02650921 ↗
Enrolled (actual)
92
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcomePrimary: Responder Rate Using Validated Hand Grading Scale — 73; 18; 12; 67 Participants — p=<0.0001

Summary

This is a randomized, evaluator-blind, split hand, multi-center study of the effectiveness and safety or Restylane Lyft with Lidocaine compared to no treatment for injection in the dorsal hand to correct volume deficits.

Outcome Measures

OutcomeResultp-value
PRIMARY
Responder Rate Using Validated Hand Grading Scale
63; 25; 20; 58 <0.0001 sig
SECONDARY
Responder Rate Using Validated Hand Grading Scale
63; 25; 20; 58 <0.0001 sig
SECONDARY
Improvement in Hand as Evaluated by IPR
71; 18; 12; 65
SECONDARY
GAIS by Treating Investigator
24; 1; 45; 0; 10; 0
SECONDARY
Evaluate GAIS by Subjects
21; 0; 34; 1; 22; 0
SECONDARY
Evaluate GAIS by Subject
21; 0; 26; 1; 30; 1
SECONDARY
Question 1 From Subject Satisfaction Questionnaire
77; 7
SECONDARY
Question 2 From Subject Satisfaction Questionnaire
74; 10
SECONDARY
Question 3 From Subject Satisfaction Questionnaire
75; 9
SECONDARY
Question 4 From Subject Satisfaction Questionnaire
44; 40
SECONDARY
Question 5 From Subject Satisfaction Questionnaire
64; 20
SECONDARY
Question 6 From Subject Satisfaction Questionnaire
78; 6
SECONDARY
Question 7 From Subject Satisfaction Questionnaire
81; 3
SECONDARY
Question 8 From Subject Satisfaction Questionnaire
59; 25
SECONDARY
Question 9 From Subject Satisfaction Questionnaire
26; 58
SECONDARY
Question 10 From Subject Satisfaction Questionnaire
57; 26
SECONDARY
Question 11 From Subject Satisfaction Questionnaire
80; 4
SECONDARY
Question 12 From Subject Satisfaction Questionnaire
71; 13
SECONDARY
Question 13 From Subject Satisfaction Questionnaire
65; 19

Eligibility Criteria

Key Inclusion Criteria

  • Subjects willing to comply with the requirements of the study and providing a signed written informed consent including release of copyright of hand images.
  • Males or females, 22 years of age or older
  • Willing and able to perform hand functionality tests .

Key Exclusion Criteria

  • History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
  • History of allergy or hypersensitivity to lidocaine or other amide type anesthetics.
  • Previous hand surgery including sclerotherapy, or history of hand trauma.
  • Advanced photo aged/ photo damaged skin or skin condition with very crinkled or fragile skin on the dorsal hands.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02650921). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search